Home

Invicta Diagnostic PE Ratio

Image

Invicta Diagnostic Ltd

NSE: InvictaDiagnos.

PE

21

Last updated on: Dec 26, 2025

Key Highlights

  • The P/E Ratio of Invicta Diagnostic Ltd is 21 as of 26 Dec 25 .
  • The P/E Ratio of Invicta Diagnostic Ltd changed from 0 on March 2024 to 0 on March 2025 . This represents a CAGR of 0.0% over 2 years.
  • The Latest Trading Price of Invicta Diagnostic Ltd is ₹ 78.3 as of 29 Dec 15:30 .
  • The PE Ratio of Healthcare Industry has changed from 34.9 to 62.0 in 5 years. This represents a CAGR of 12.18%.
  • The PE Ratio of Automobile industry is 21.6. The PE Ratio of Finance industry is 19.0. The PE Ratio of Healthcare industry is 63.0. The PE Ratio of IT - Software industry is 27.7. The PE Ratio of Retail industry is 123.5. The PE Ratio of Textiles industry is 55.0 in 2025.

Historical P/E Ratio of Invicta Diagnostic Ltd

No data available

Company Fundamentals for Invicta Diagnostic Ltd

Image

Invicta Diagnostic Ltd

NSE: InvictaDiagnos.

Share Price

₹ 78.3

-0.10 (-0.13%)

stock direction

Last updated on: Dec 29, 2025

Market Price of Invicta Diagnostic Ltd

1M

1Y

3Y

5Y

Monitoring Invicta Diagnostic Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 202578.4
24 Dec 202580
23 Dec 202580.65
22 Dec 202581.3
19 Dec 202581.85
18 Dec 202583
17 Dec 202585.35
16 Dec 202586.85
15 Dec 202588
12 Dec 202586.35

BlinkX Score for Invicta Diagnostic Ltd

Asset Value vs Market Value of Invicta Diagnostic Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Invicta Diagnostic Ltd Explained

98.56

Market cap

5

Earnings

18.3X

PE Ratio

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Invicta Diagnostic Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Invicta Diagnostic Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Invicta Diagnostic Ltd

No data available

* All values are in %

About Invicta Diagnostic Ltd

  • Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name 'Invicta Diagnostic LLP' vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre.
  • Further, Invicta Diagnostic LLP converted into a Private Limited Company as 'Invicta Diagnostic Private Limited' dated December 01, 2023.
  • Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to 'Invicta Diagnostic Limited' and a fresh Certificate of Incorporation dated July 02, 2024 was issued to the Company by the Assistant Registrar of Companies, Central Processing Centre. Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology and pathology solutions.

Invicta Diagnostic Ltd News Hub

NSE SME Invicta Diagnostic starts with a healthy lift

The stock listed at Rs 100, a 17.65% premium to the IPO price, and is currently frozen at its lower

Read more

08 Dec 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions